Compare TLX & FHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLX | FHB |
|---|---|---|
| Founded | 2015 | 1858 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | N/A | 2016 |
| Metric | TLX | FHB |
|---|---|---|
| Price | $7.08 | $27.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | $21.00 | ★ $27.50 |
| AVG Volume (30 Days) | 171.4K | ★ 1.7M |
| Earning Date | 01-19-2026 | 01-30-2026 |
| Dividend Yield | N/A | ★ 3.82% |
| EPS Growth | N/A | ★ 22.91 |
| EPS | 0.04 | ★ 2.20 |
| Revenue | $664,225,558.00 | ★ $853,588,000.00 |
| Revenue This Year | N/A | $6.97 |
| Revenue Next Year | N/A | $3.70 |
| P/E Ratio | $166.51 | ★ $12.38 |
| Revenue Growth | ★ 55.35 | 7.53 |
| 52 Week Low | $6.87 | $20.32 |
| 52 Week High | $30.36 | $28.35 |
| Indicator | TLX | FHB |
|---|---|---|
| Relative Strength Index (RSI) | 39.32 | 54.45 |
| Support Level | $6.87 | $26.54 |
| Resistance Level | $8.45 | $27.43 |
| Average True Range (ATR) | 0.24 | 0.91 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 12.03 | 50.00 |
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.